Novartis Satellite Symposia at the Virtual ESMO Congress 2021
Cutting through the noise: How Do GEP-NET Patients Stand to Benefit From PRRT?
September 20, 2021 I 8:45 - 10:15 CEST I Channel 6
Actionable Targets in Advanced Prostate Cancer: The Potential of Molecular Profiling and Radioligand Therapy
September 20, 2021 I 10:30 - 12:00 CEST I Channel 6